CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income (loss)	$ (1,109,406)	$ 408,295
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	35,519	57,486
Amortization of debt discount on notes payable	2,148	75,705
Amortization of right of use assets	21,512	333,777
Gain on debt extinguishment	0	(754,000)
Share-based payment compensation	8,184	4,471
Provision for (recovery of) returns and doubtful accounts	(18,740)	0
Deferred income taxes (benefit)	0	7,878
Changes in operating assets and liabilities:
Accounts receivable	2,044,122	(129,714)
Prepaid expenses and other current assets	(222,019)	(250,034)
Contract assets	13,120	30,179
Inventory	7,667	0
Other assets	5,437	(1,031)
Accounts payable	389,847	536,721
Accrued expenses and other long-term liabilities	(259,405)	131,288
Operating lease liabilities	(21,512)	(429,112)
Deferred revenue	(682,055)	115,750
Net cash provided by (used in) operating activities	214,419	137,659
Cash flows from investing activities:
Purchases of property and equipment	0	(41,121)
Security deposits	0	1,588
Net cash provided by (used in) investing activities	0	(39,533)
Cash flows from financing activities:
Net cash provided by (used in) financing activities	0	0
Effect of exchange rate changes on cash and cash equivalents	(13,989)	2,207
Net increase (decrease) in cash and cash equivalents	200,430	100,333
Cash and cash equivalents, beginning of period	3,181,209	1,920,656
Cash and cash equivalents, end of period	3,381,639	2,020,989
Supplemental disclosures:
Cash paid for interest	21,554	75,816
Non-cash investing and financing activities:
Undistributed Series A redeemable convertible preferred stock dividends	300,921	277,170
Accretion of Series A redeemable convertible preferred stock	$ 14,815	$ 197,114